• Home
  • Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S

About Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech is a leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specializes in producing pharma-grade Benzalkonium Chloride used as APIs and excipients and Recombinant Insulin for use in cell culture media to enhance cell growth and viability, and productivity. 

Helping the world´s largest ...

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DK
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info

Products from Novo Nordisk Pharmatech A/S (3)

  • BAC

    Product BAC

    Benzalkonium Chloride Ph.Eur., USP/NF (BKC/BAC/BAK) CAS No. 8001-54-5 Consists of Benzyl (dodecyl) dimethyl ammonium chloride (C12 approx. 65%) and Benzyl (tetradecyl) dimethyl ammonium chloride (C14 approx. 35%). Other chain length distributions are also available. Available with more than 95% active ...
  • Benzalkonium Chloride

    Product Benzalkonium Chloride

    CAS No. 8001-54-5. Our standard product consists of Benzyl (dodecyl) dimethyl ammonium chloride (C12 approx. 65%) and Benzyl (tetradecyl) dimethyl ammonium chloride (C14 approx. 35%). Other chain length distributions are also available. Available with more than 95% active ingredient or in 50% Solution. ...
  • BKC

    Product BKC

    Benzalkonium Chloride Ph.Eur., USP/NF (BKC/BAC/BAK) CAS No. 8001-54-5 Consists of Benzyl (dodecyl) dimethyl ammonium chloride (C12 approx. 65%) and Benzyl (tetradecyl) dimethyl ammonium chloride (C14 approx. 35%). Other chain length distributions are also available.Available with more than 95% active i...

Novo Nordisk Pharmatech A/S Resources (2)

  • Novavax sells Czech production plant to Novo Nordisk for $200M

    News Novavax sells Czech production plant to Novo Nordisk for $200M

    Novavax has sold its Czech manufacturing facility to Novo Nordisk for $200 million, including the site’s 300 employees, in a move to cut costs and focus on vaccine development.
    17 Dec 2024
  • Novo Nordisk Pharmatech corporate video

    Video Novo Nordisk Pharmatech corporate video

    Novo Nordisk Pharmatech is a global and leading supplier of quaternary ammonium compound which is used both as an API and as an excipient to many different customer applications. 

    Novo Nordisk Pharmatech is also a global and leading supplier of insulin which is used for cell media media.
    2021-11-02